Tremfya on The Journal.

The Journal.May 20, 2026

Why Chinese Customers Are Running From Nike

1:02
mid-roll
Kate Linebaugh, Ryan Knutson
The Wall Street Journal & Spotify Studios
May 20, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 1:02
@ 12:28 in ep

Estimated current placement value

Low confidence
~$960range $180$6,600

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 200 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 1:02 · Unknown · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

If you've been diagnosed with moderate to severe plaque psoriasis, this is what it sounds like to be a million miles away. Imagine being a million miles away. Tremfya couselkumab, taken by injection, is a prescription medicine for adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills or phototherapy. With Tremfya, clearer skin is possible. In clinical trials, at least seventy percent of patients saw at least ninety percent clearer skin at sixteen weeks. Results may vary. Tremfya is also indicated for adults with active psoriatic arthritis. Serious allergic reactions and increased risk of infections and liver problems may occur. Before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms, or if you need a vaccine. Tap this ad to learn more about Tremfya, including important safety information.

Auto-transcribed · verbatim audio matches · Report an error

Episode

The Journal.
Why Chinese Customers Are Running From Nike
Hosts: Kate Linebaugh, Ryan Knutson
Publisher: The Wall Street Journal & Spotify Studios